IIA
NVO

ICW Investment Advisors’s Novo Nordisk NVO Stock Holding History

ICW Investment Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16M Buy
45,035
+294
+0.7% +$12.6K 0.76% 52
2026
Q1 		$1.64M Buy
44,741
+401
+0.9% +$19K 0.59% 67
2025
Q4 		$2.26M Sell
44,340
-235
-0.5% -$12K 0.82% 43
2025
Q3 		$2.47M Buy
44,575
+2,349
+6% +$137K 0.89% 39
2025
Q2 		$2.91M Buy
42,226
+939
+2% +$63.9K 1.15% 26
2025
Q1 		$2.87M Buy
41,287
+145
+0.4% +$12K 1.17% 23
2024
Q4 		$3.54M Buy
41,142
+472
+1% +$51K 1.48% 15
2024
Q3 		$4.84M Sell
40,670
-827
-2% -$110K 2.02% 6
2024
Q2 		$5.92M Sell
41,497
-843
-2% -$112K 2.69% 2
2024
Q1 		$5.44M Sell
42,340
-378
-0.9% -$45K 2.42% 2
2023
Q4 		$4.42M Sell
42,718
-1,278
-3% -$126K 2.15% 4
2023
Q3 		$4M Buy
43,996
+152
+0.3% +$13.4K 2.15% 4
2023
Q2 		$3.55M Buy
43,844
+126
+0.3% +$10.3K 1.9% 7
2023
Q1 		$3.48M Buy
43,718
+158
+0.4% +$11.2K 1.98% 7
2022
Q4 		$2.95M Sell
43,560
-670
-2% -$39.3K 1.77% 9
2022
Q3 		$2.2M Buy
44,230
+210
+0.5% +$11.3K 1.48% 14
2022
Q2 		$2.45M Sell
44,020
-62
-0.1% -$3.44K 1.56% 13
2022
Q1 		$2.45M Sell
44,082
-14
-0% -$719 1.41% 14
2021
Q4 		$2.47M Buy
44,096
+138
+0.3% +$7.48K 1.38% 16
2021
Q3 		$2.11M Buy
43,958
+166
+0.4% +$8.03K 1.36% 16
2021
Q2 		$1.83M Buy
43,792
+624
+1% +$24.2K 1.2% 25
2021
Q1 		$1.46M Buy
43,168
+442
+1% +$15.7K 1% 39
2020
Q4 		$1.5M Sell
42,726
-440
-1% -$15.2K 1.07% 37
2020
Q3 		$1.5M Buy
43,166
+576
+1% +$19.2K 1.12% 35
2020
Q2 		$1.39M Buy
42,590
+258
+0.6% +$8.23K 1.13% 29
2020
Q1 		$1.27M Buy
42,332
+758
+2% +$22.6K 1.21% 28
2019
Q4 		$1.2M Buy
+41,574
New +$1.15M 0.98% 43

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

ICW Investment Advisors's NVO Position: Q2 2026 in Review

ICW Investment Advisors increased its Novo Nordisk (NVO) stake by 0.66% in Q2 2026, buying an estimated $12.6K and bringing the position to 45,035 shares worth $2.16M. The position accounts for 0.76% of the portfolio, ranked #52.

ICW Investment Advisors first reported a position in NVO in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.92M in Q2 2024. 1,355 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • ICW Investment Advisors held 45,035 shares of Novo Nordisk worth $2.16M as of Q2 2026.
  • ICW Investment Advisors bought 294 Novo Nordisk shares in Q2 2026, an estimated $12.6K.
  • Novo Nordisk made up 0.76% of ICW Investment Advisors's portfolio in Q2 2026, its #52 holding.
  • ICW Investment Advisors first reported a position in Novo Nordisk in Q4 2019 and has held it in 27 quarters since.
  • ICW Investment Advisors's Novo Nordisk position peaked at $5.92M in Q2 2024.
  • 1,355 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on ICW Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.